TLDR AGA patients have a lower quality of life than AA patients.
The study compared the quality of life (QoL) between patients with androgenetic alopecia (AGA) and alopecia areata (AA) using the hair-specific Skindex-29 score. It found that AGA patients had significantly higher symptom scale scores than AA patients. QoL in AGA patients was more affected if the onset age was in their 20s, the disease duration was less than 6 months or more than 5 years, and the severity was mild. For AA patients, QoL was more impacted if the onset age was in their 30s and the severity was moderate. The study highlighted the need for clinicians to understand the specific factors affecting QoL in AGA and AA patients to improve patient well-being.
March 2024 in “Healthcare” Stem cell treatment improved life quality and sexual function in women with hair loss.
April 2016 in “Journal of The American Academy of Dermatology” Alopecia areata affects quality of life more than androgenetic alopecia.
8 citations,
July 2021 in “Patient Preference and Adherence” Alopecia treatments improve life quality but side effects can lessen this benefit; better use of quality of life measures is needed.
10 citations,
January 2023 in “Journal of the European Academy of Dermatology and Venereology” Alopecia areata greatly affects people's life quality, mental health, and work life.
May 2018 in “Actas Dermo-Sifiliográficas” The Spanish version of the Hair Specific Skindex-29 is a reliable tool for measuring quality of life in Spanish-speaking women with hair loss.
23 citations,
August 2018 in “Anais Brasileiros De Dermatologia” Both androgenetic alopecia and alopecia areata negatively impact quality of life, with no significant difference between them.
